IL1B and neoplasm: Experimental evidence across most cancer types, supports a tumor-promoting role for IL1β [reviewed (Maund et al., 2013; Ridker et al., 2017; Baker et al., 2019; Gelfo et al., 2020)] making IL1β a target with clear therapeutic potential.